{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:12:43Z","timestamp":1783465963309,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T00:00:00Z","timestamp":1492041600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10787-017-0329-0","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T04:53:23Z","timestamp":1492059203000},"page":"599-609","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis"],"prefix":"10.1007","volume":"26","author":[{"given":"Maria Eduarda Rocha de","family":"Fran\u00e7a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sura Wanessa Santos","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma Helena","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laise Aline","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Gabrielle Vasconcelos","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla Patr\u00edcia Sousa","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Karolina Santana","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Barros","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniele Bezerra","family":"L\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Alves","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"key":"329_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1365-2559.2005.02226.x","volume":"47","author":"N Akpolat","year":"2005","unstructured":"Akpolat N, Yahsi S, Godekmerdan A et al (2005) The value of \u03b1-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study. Histopathology 47:276\u2013280. doi:\n                        10.1111\/j.1365-2559.2005.02226.x","journal-title":"Histopathology"},{"key":"329_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI200524282.The","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner D (2005) Science in medicine liver fibrosis. J Clin Invest 115:209\u2013218. doi:\n                        10.1172\/JCI200524282.The","journal-title":"J Clin Invest"},{"key":"329_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1053\/jhep.2001.28457","volume":"34","author":"DM Bissell","year":"2001","unstructured":"Bissell DM, Roulot D, George J (2001) Transforming growth factor beta and the liver. Hepatology 34:859\u2013867. doi:\n                        10.1053\/jhep.2001.28457","journal-title":"Hepatology"},{"key":"329_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000329800","volume":"29","author":"A Bosserhoff","year":"2011","unstructured":"Bosserhoff A, Hellerbrand C (2011) Obesity and fatty liver are \u201cgrease\u201d for the machinery of hepatic fibrosis. Dig Dis 29:377\u2013383. doi:\n                        10.1159\/000329800","journal-title":"Dig Dis"},{"key":"329_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","volume":"37","author":"G Carpino","year":"2005","unstructured":"Carpino G, Morini S, Ginanni Corradini S et al (2005) Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis 37:349\u2013356. doi:\n                        10.1016\/j.dld.2004.11.009","journal-title":"Dig Liver Dis"},{"key":"329_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/j.1478-3231.2010.02256.x","volume":"30","author":"E Ch\u00e1vez","year":"2010","unstructured":"Ch\u00e1vez E, Segovia J, Shibayama M et al (2010) Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat. Liver Int 30:969\u2013978. doi:\n                        10.1111\/j.1478-3231.2010.02256.x","journal-title":"Liver Int"},{"key":"329_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1055\/s-0029-1214376","volume":"29","author":"FJ Cubero","year":"2009","unstructured":"Cubero FJ, Urtasun R, Nieto N (2009) Alcohol and liver fibrosis. Semin Liver Dis 29:211\u2013221. doi:\n                        10.1055\/s-0029-1214376","journal-title":"Semin Liver Dis"},{"key":"329_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman SL (2008a) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88:125\u2013172. doi:\n                        10.1152\/physrev.00013.2007","journal-title":"Physiol Rev"},{"key":"329_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","volume":"254","author":"SL Friedman","year":"2008","unstructured":"Friedman SL (2008b) Hepatic fibrosis\u2014overview. Toxicology 254:120\u2013129. doi:\n                        10.1016\/j.tox.2008.06.013","journal-title":"Toxicology"},{"key":"329_CR10","doi-asserted-by":"publisher","first-page":"167sr1","DOI":"10.1126\/scitranslmed.3004700","volume":"5","author":"SL Friedman","year":"2013","unstructured":"Friedman SL, Sheppard D, Duffield JS, Violette S (2013) Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med 5:167sr1. doi:\n                        10.1126\/scitranslmed.3004700","journal-title":"Sci Transl Med"},{"key":"329_CR11","first-page":"495","volume":"15","author":"R Gonzalez","year":"1994","unstructured":"Gonzalez R, Ancheta O, Marquez M, Rodriguez S (1994) Hepatoprotective effects of diethylcarbamazine in acute liver damage induced by carbon tetrachloride in rats. Acta Pharmacol Sin 15:495\u2013497","journal-title":"Acta Pharmacol Sin"},{"key":"329_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cca.2014.02.021","volume":"433","author":"OA Gressner","year":"2014","unstructured":"Gressner OA, Gao CA (2014) Monitoring fibrogenic progression in the liver. Clin Chim Acta 433:111\u2013122. doi:\n                        10.1016\/j.cca.2014.02.021","journal-title":"Clin Chim Acta"},{"key":"329_CR13","doi-asserted-by":"publisher","first-page":"d793","DOI":"10.2741\/gressner","volume":"7","author":"AM Gressner","year":"2002","unstructured":"Gressner AM, Weiskirchen R, Breitkopf K, Dooley S (2002) Roles of TGF-beta in hepatic fibrosis. Front Biosci 7:d793\u2013d807. doi:\n                        10.2741\/gressner","journal-title":"Front Biosci"},{"key":"329_CR14","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","volume":"46","author":"S Hemmann","year":"2007","unstructured":"Hemmann S, Graf J, Roderfeld M, Roeb E (2007) Expression of MMPs and TIMPs in liver fibrosis\u2014a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 46:955\u2013975. doi:\n                        10.1016\/j.jhep.2007.02.003","journal-title":"J Hepatol"},{"key":"329_CR15","first-page":"1304","volume":"32","author":"RI Hewitt","year":"1947","unstructured":"Hewitt RI (1947) Experimental chemotherapy of filariasis; effect of piperazine derivatives against naturally acquired filarial infections in cotton rats and dogs. J Lab Clin Med 32:1304\u20131313","journal-title":"J Lab Clin Med"},{"key":"329_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/pin.12094","volume":"63","author":"IH Hong","year":"2013","unstructured":"Hong IH, Park SJ, Goo MJ et al (2013) JNK1 and JNK2 regulate \u03b1-SMA in hepatic stellate cells during CCl4-induced fibrosis in the rat liver. Pathol Int 63:483\u2013491. doi:\n                        10.1111\/pin.12094","journal-title":"Pathol Int"},{"key":"329_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1172\/JCI30542","volume":"117","author":"JP Iredale","year":"2007","unstructured":"Iredale JP (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117:539\u2013548. doi:\n                        10.1172\/JCI30542","journal-title":"J Clin Invest"},{"key":"329_CR18","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.cca.2010.04.009","volume":"411","author":"P Jar\u010du\u0161ka","year":"2010","unstructured":"Jar\u010du\u0161ka P, Jani\u010dko M, Vesel\u00edny E et al (2010) Circulating markers of liver fibrosis progression. Clin Chim Acta 411:1009\u20131017. doi:\n                        10.1016\/j.cca.2010.04.009","journal-title":"Clin Chim Acta"},{"key":"329_CR19","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","volume":"298","author":"GL Johnson","year":"2002","unstructured":"Johnson GL, Johnson GL, Lapadat R, Lapadat R (2002) Mitogen-activated protein kinase pathways Mediated by ERK, JNK, and p38 protein kinases. Science (80-) 298:1911\u20131912","journal-title":"Science (80-)"},{"key":"329_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1053\/j.gastro.2009.09.015","volume":"138","author":"J Kluwe","year":"2010","unstructured":"Kluwe J, Pradere JP, Gwak GY et al (2010) Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. Gastroenterology 138:347\u2013359. doi:\n                        10.1053\/j.gastro.2009.09.015","journal-title":"Gastroenterology"},{"key":"329_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fphys.2012.00069","volume":"3","author":"X Kong","year":"2012","unstructured":"Kong X, Horiguchi N, Mori M, Gao B (2012) Cytokines and STATs in liver fibrosis. Front Physiol 3:69. doi:\n                        10.3389\/fphys.2012.00069","journal-title":"Front Physiol"},{"key":"329_CR22","first-page":"749","volume":"35","author":"Y Kweon","year":"2001","unstructured":"Kweon Y, Kweon Y, Goodman ZD et al (2001) Decreasing brogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Clin Invest 35:749\u2013755","journal-title":"J Clin Invest"},{"key":"329_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","volume":"25","author":"UE Lee","year":"2011","unstructured":"Lee UE, Friedman SL (2011) Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 25:195\u2013206. doi:\n                        10.1016\/j.bpg.2011.02.005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"329_CR24","first-page":"201","volume":"26","author":"T-M Leung","year":"2011","unstructured":"Leung T-M, Fung M-L, Liong EC et al (2011) Role of nitric oxide in the regulation of fibrogenic factors in experimental liver fibrosis in mice. Histol Histopathol 26:201\u2013211","journal-title":"Histol Histopathol"},{"key":"329_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jep.2012.05.040","volume":"142","author":"X Lin","year":"2012","unstructured":"Lin X, Zhang S, Huang Q et al (2012) Protective effect of Fufang\u2013Liu\u2013Yue\u2013Qing, a traditional Chinese herbal formula, on CCl4 induced liver fibrosis in rats. J Ethnopharmacol 142:548\u2013556. doi:\n                        10.1016\/j.jep.2012.05.040","journal-title":"J Ethnopharmacol"},{"key":"329_CR26","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1017\/S0031182000075351","volume":"105","author":"RM Maizels","year":"1992","unstructured":"Maizels RM, Denham DA (1992) Diethilcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug. Parasitology 105:849\u2013860","journal-title":"Parasitology"},{"key":"329_CR27","first-page":"1159","volume":"15","author":"R McCrudden","year":"2000","unstructured":"McCrudden R, Iredale JP (2000) Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases. Histol Histopathol 15:1159\u20131168","journal-title":"Histol Histopathol"},{"key":"329_CR28","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/hep.20618","volume":"41","author":"FF Mohammed","year":"2005","unstructured":"Mohammed FF, Pennington CJ, Kassiri Z et al (2005) Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology 41:857\u2013867. doi:\n                        10.1002\/hep.20618","journal-title":"Hepatology"},{"key":"329_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cbi.2011.07.001","volume":"193","author":"E Mormone","year":"2011","unstructured":"Mormone E, George J, Nieto N (2011) Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact 193:225\u2013231. doi:\n                        10.1016\/j.cbi.2011.07.001","journal-title":"Chem Biol Interact"},{"key":"329_CR30","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/hep.20425","volume":"40","author":"CJ Parsons","year":"2004","unstructured":"Parsons CJ, Bradford BU, Pan CQ et al (2004) Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats. Hepatology 40:1106\u20131115. doi:\n                        10.1002\/hep.20425","journal-title":"Hepatology"},{"key":"329_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejphar.2014.03.046","volume":"734C","author":"CA Peixoto","year":"2014","unstructured":"Peixoto CA, Silva BS (2014) Anti-inflammatory effects of diethylcarbamazine: a review. Eur J Pharmacol 734C:35\u201341. doi:\n                        10.1016\/j.ejphar.2014.03.046","journal-title":"Eur J Pharmacol"},{"key":"329_CR32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/j.1365-2893.2011.01481.x","volume":"18","author":"A Probst","year":"2011","unstructured":"Probst A, Dang T, Bochud M et al (2011) Role of Hepatitis C virus genotype 3 in liver fibrosis progression\u2014a systematic review and meta-analysis. J Viral Hepat 18:745\u2013759. doi:\n                        10.1111\/j.1365-2893.2011.01481.x","journal-title":"J Viral Hepat"},{"key":"329_CR33","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1038\/sj.onc.1210392","volume":"26","author":"M Raman","year":"2007","unstructured":"Raman M, Chen W, Cobb MH (2007) Differential regulation and properties of MAPKs. Oncogene 26:3100\u20133112. doi:\n                        10.1038\/sj.onc.1210392","journal-title":"Oncogene"},{"key":"329_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0955-0674(97)80061-0","volume":"9","author":"MJ Robinson","year":"1997","unstructured":"Robinson MJ, Cobb MH (1997) Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9:180\u2013186. doi:\n                        10.1016\/S0955-0674(97)80061-0","journal-title":"Curr Opin Cell Biol"},{"key":"329_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/696383","volume":"2014","author":"SWS Rocha","year":"2014","unstructured":"Rocha SWS, De Fran\u00e7a MER, Rodrigues GB et al (2014) Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride-(CCl4-) induced liver injury in mice. Mediators Inflamm 2014:1\u201315. doi:\n                        10.1155\/2014\/696383","journal-title":"Mediators Inflamm"},{"key":"329_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/1440-1681.12369","volume":"42","author":"GB Rodrigues","year":"2015","unstructured":"Rodrigues GB, Rocha SWS, Dos Santos LAM et al (2015) Diethylcarbamazine: possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL\/6 mice. Clin Exp Pharmacol Physiol 42:369\u2013379. doi:\n                        10.1111\/1440-1681.12369","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"329_CR37","first-page":"524","volume":"20","author":"SW Santos Rocha","year":"2012","unstructured":"Santos Rocha SW, Oliveira Dos Santos AC, Dos Santos Silva B et al (2012a) Effects of diethylcarbamazine (DEC) on hepatocytes of C57BL\/6\u00a0J mice submitted to protein malnutrition. J Food Drug Anal 20:524\u2013531","journal-title":"J Food Drug Anal"},{"key":"329_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejphar.2012.05.044","volume":"689","author":"SW Santos Rocha","year":"2012","unstructured":"Santos Rocha SW, Santos Silva B, Dos Santos Gomes FO et al (2012b) Effect of diethylcarbamazine on chronic hepatic inflammation induced by alcohol in C57BL\/6 mice. Eur J Pharmacol 689:194\u2013203. doi:\n                        10.1016\/j.ejphar.2012.05.044","journal-title":"Eur J Pharmacol"},{"key":"329_CR39","doi-asserted-by":"publisher","first-page":"130067","DOI":"10.1098\/rsob.130067","volume":"3","author":"GP Sapkota","year":"2013","unstructured":"Sapkota GP (2013) The TGF\u03b2-induced phosphorylation and activation of p38 mitogen-activated protein kinase is mediated by MAP3K4 and MAP3K10 but not TAK1. Open Biol 3:130067. doi:\n                        10.1098\/rsob.130067","journal-title":"Open Biol"},{"key":"329_CR40","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI66028.The","volume":"123","author":"D Schuppan","year":"2013","unstructured":"Schuppan D, Kim YO (2013) Review series evolving therapies for liver fi brosis. 123:1887\u20131901. doi:\n                        10.1172\/JCI66028.The","journal-title":"Review series evolving therapies for liver fi brosis."},{"key":"329_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-2001-17556","volume":"21","author":"D Schuppan","year":"2001","unstructured":"Schuppan D, Ruehl M, Somasundaram R, Hahn EG (2001) Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 21:351\u2013372. doi:\n                        10.1055\/s-2001-17556","journal-title":"Semin Liver Dis"},{"key":"329_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.22952","volume":"50","author":"E Seki","year":"2009","unstructured":"Seki E, de Minicis S, Inokuchi S et al (2009) CCR2 promotes hepatic fibrosis in mice. Hepatology 50:185\u2013197. doi:\n                        10.1002\/hep.22952","journal-title":"Hepatology"},{"key":"329_CR43","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/jn\/131.7.2067","volume":"131","author":"A Terpstra","year":"2001","unstructured":"Terpstra A (2001) Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: role of metabolic rate. J Nutr 131:2067\u20132068","journal-title":"J Nutr"},{"key":"329_CR44","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0006-291X(03)00087-1","volume":"301","author":"J Tock","year":"2003","unstructured":"Tock J, Van Putten V, Stenmark KR, Nemenoff RA (2003) Induction of SM-\u03b1-actin expression by mechanical strain in adult vascular smooth muscle cells is mediated through activation of JNK and p38 MAP kinase. Biochem Biophys Res Commun 301:1116\u20131121. doi:\n                        10.1016\/S0006-291X(03)00087-1","journal-title":"Biochem Biophys Res Commun"},{"key":"329_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cca.2005.06.014","volume":"364","author":"S Tsukada","year":"2006","unstructured":"Tsukada S, Parsons CJ, Rippe RA (2006) Mechanisms of liver fibrosis. Clin Chim Acta 364:33\u201360. doi:\n                        10.1016\/j.cca.2005.06.014","journal-title":"Clin Chim Acta"},{"key":"329_CR46","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/cmi.2011.53","volume":"9","author":"R Xu","year":"2012","unstructured":"Xu R, Zhang Z, Wang F-S (2012) Liver fibrosis: mechanisms of immune-mediated liver injury. Cell Mol Immunol 9:296\u2013301. doi:\n                        10.1038\/cmi.2011.53","journal-title":"Cell Mol Immunol"},{"key":"329_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2014.00167","volume":"5","author":"J Xu","year":"2014","unstructured":"Xu J, Liu X, Koyama Y et al (2014) The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Front Pharmacol 5:1\u201312. doi:\n                        10.3389\/fphar.2014.00167","journal-title":"Front Pharmacol"},{"key":"329_CR48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.toxlet.2013.06.240","volume":"222","author":"Q Yao","year":"2013","unstructured":"Yao Q, Lin Y, Li X et al (2013) Curcumin ameliorates intrahepatic angiogenesis and capillarization of the sinusoids in carbon tetrachloride-induced rat liver fibrosis. Toxicol Lett 222:72\u201382. doi:\n                        10.1016\/j.toxlet.2013.06.240","journal-title":"Toxicol Lett"},{"key":"329_CR49","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1053\/jhep.2002.32673","volume":"35","author":"Y Yata","year":"2002","unstructured":"Yata Y, Gotwals P, Koteliansky V, Rockey DC (2002) Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy. Hepatology 35:1022\u20131030. doi:\n                        10.1053\/jhep.2002.32673","journal-title":"Hepatology"},{"key":"329_CR50","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0270-9139(02)00091-5","volume":"36","author":"H Yoshiji","year":"2002","unstructured":"Yoshiji H, Kuriyama S, Yoshii J et al (2002) Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 36:850\u2013860. doi:\n                        10.1016\/S0270-9139(02)00091-5","journal-title":"Hepatology"},{"key":"329_CR51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/cr.2008.328.Non-Smad","volume":"19","author":"YE Zhang","year":"2009","unstructured":"Zhang YE (2009) Non-Smad pathways in TGF-\u03b2 signaling. Cell Res 19:128\u2013139. doi:\n                        10.1038\/cr.2008.328.Non-Smad","journal-title":"Cell Res"},{"key":"329_CR52","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1161\/01.CIR.0000050653.10758.6B","volume":"107","author":"L Zhao","year":"2003","unstructured":"Zhao L (2003) Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic peptide activity. Circulation 107:234\u2013237. doi:\n                        10.1161\/01.CIR.0000050653.10758.6B","journal-title":"Circulation"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-017-0329-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-017-0329-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-017-0329-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T09:58:21Z","timestamp":1521453501000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-017-0329-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["329"],"URL":"https:\/\/doi.org\/10.1007\/s10787-017-0329-0","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]}}}